Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Stiewe

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Nature Genetics|December 2, 2000
Role of the p53-homologue p73 in E2F1-induced apoptosisT Stiewe, B M Pützer
Apoptosis : an International Journal on Programmed Cell Death|October 12, 2001
p73 in apoptosisT Stiewe, B M Pützer
Cell Death and Differentiation|February 23, 2002
Role of p73 in malignancy: tumor suppressor or oncogene?T Stiewe, B M Pützer
Human Gene Therapy|July 19, 2003
Antitumor capacity of a dominant-negative RET proto-oncogene mutant in a medullary thyroid carcinoma modelM Drosten, T Stiewe, B M Pützer
Cancer Research|October 5, 2001
Therapeutic efficacy of E2F1 in pancreatic cancer correlates with TP73 inductionF Rödicker, T Stiewe, S Zimmermann, et al.
Cell Death and Differentiation|May 3, 2003
Increased DeltaN-p73 expression in tumors by upregulation of the E2F1-regulated, TA-promoter-derived DeltaN'-p73 transcriptB M Pützer, S Tuve, A Tannapfel, et al.
Gene Therapy|August 5, 2000
Improved safety through tamoxifen-regulated induction of cytotoxic genes delivered by Ad vectors for cancer gene therapyB M Pützer, T Stiewe, F Crespo, et al.
Oncogene|October 6, 2005
Regulation of telomerase activity by the p53 family member p73M Beitzinger, C Oswald, R Beinoraviciute-Kellner, et al.
Cell Death and Differentiation|March 14, 2000
E1A is sufficient by itself to induce apoptosis independent of p53 and other adenoviral gene productsB M Pützer, T Stiewe, K Parssanedjad, et al.
Cancer Research|August 5, 2000
E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agentsT Stiewe, K Parssanedjad, H Esche, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Nature Genetics|December 2, 2000
Role of the p53-homologue p73 in E2F1-induced apoptosisT Stiewe, B M Pützer
Apoptosis : an International Journal on Programmed Cell Death|October 12, 2001
p73 in apoptosisT Stiewe, B M Pützer
Cell Death and Differentiation|February 23, 2002
Role of p73 in malignancy: tumor suppressor or oncogene?T Stiewe, B M Pützer
Human Gene Therapy|July 19, 2003
Antitumor capacity of a dominant-negative RET proto-oncogene mutant in a medullary thyroid carcinoma modelM Drosten, T Stiewe, B M Pützer
Cancer Research|October 5, 2001
Therapeutic efficacy of E2F1 in pancreatic cancer correlates with TP73 inductionF Rödicker, T Stiewe, S Zimmermann, et al.
Cell Death and Differentiation|May 3, 2003
Increased DeltaN-p73 expression in tumors by upregulation of the E2F1-regulated, TA-promoter-derived DeltaN'-p73 transcriptB M Pützer, S Tuve, A Tannapfel, et al.
Gene Therapy|August 5, 2000
Improved safety through tamoxifen-regulated induction of cytotoxic genes delivered by Ad vectors for cancer gene therapyB M Pützer, T Stiewe, F Crespo, et al.
Oncogene|October 6, 2005
Regulation of telomerase activity by the p53 family member p73M Beitzinger, C Oswald, R Beinoraviciute-Kellner, et al.
Cell Death and Differentiation|March 14, 2000
E1A is sufficient by itself to induce apoptosis independent of p53 and other adenoviral gene productsB M Pützer, T Stiewe, K Parssanedjad, et al.
Cancer Research|August 5, 2000
E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agentsT Stiewe, K Parssanedjad, H Esche, et al.
Pageof 2